Buprenorphine/Naloxone (Suboxone) Home Induction for People Living With HIV With Opioid Use Disorder
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
This report highlights projects found to offer highly effective (and replicable) approaches to integrating buprenorphine-based medication-assisted treatment into HIV/AIDS primary care. Chapters outline the processes programs need to put in place, including meeting DATA 2000 regulatory requirements, achieving institutional buy-in, implementing staff training requirements, and evaluating processes and outcomes.
Resource updated 04/02/2024
Resource updated 04/08/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource updated 06/06/2024
Resource updated 09/14/2023
Resource updated 10/24/2023
Resource updated 05/23/2023
Resource updated 03/15/2023
Resource updated 06/09/2022
Resource updated 02/28/2023
Resource updated 03/04/2024
Resource updated 05/15/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource updated 09/19/2023
Resource updated 01/08/2024